Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Charter Communications
CHTR
|
+$601M |
| 2 |
Parker-Hannifin
PH
|
+$576M |
| 3 |
JPMorgan Chase
JPM
|
+$575M |
| 4 |
Goldman Sachs
GS
|
+$452M |
| 5 |
FedEx
FDX
|
+$371M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$733M |
| 2 |
American Tower
AMT
|
+$684M |
| 3 |
Nike
NKE
|
+$601M |
| 4 |
AGN
Allergan plc
AGN
|
+$561M |
| 5 |
McDonald's
MCD
|
+$536M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.7% |
| 2 | Consumer Discretionary | 17.46% |
| 3 | Healthcare | 13.37% |
| 4 | Communication Services | 12.12% |
| 5 | Financials | 11.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
451
Neurocrine Biosciences
NBIX
$18.4B
| $14.3M | 0.02% |
369,409
+1,253
| +0.3% | +$56.7K |
|
452
Cousins Properties
CUZ
$5.22B
| $14.1M | 0.02% |
+413,459
| New | +$13M |
|
|
ICD
453
DELISTED
Independence Contract Drilling, Inc.
ICD
| $14M | 0.02% |
104,704
-3,443
| -3% | -$386K |
|
|
BWP
454
DELISTED
Boardwalk Pipeline Partners
BWP
| $13.9M | 0.02% |
798,599
+42,775
| +6% | +$731K |
|
455
Bloomin' Brands
BLMN
$736M
| $13.4M | 0.02% |
743,004
-249,296
| -25% | -$4.52M |
|
|
MB
456
DELISTED
MINDBODY, Inc. Class A Common Stock
MB
| $13.2M | 0.01% |
+617,908
| New | +$12.5M |
|
|
ZEN
457
DELISTED
ZENDESK INC
ZEN
| $13M | 0.01% |
613,098
+327,231
| +114% | +$7.92M |
|
|
TBI
458
Trueblue
TBI
$235M
| $12.9M | 0.01% |
521,434
-275,122
| -35% | -$5.8M |
|
|
EQM
459
DELISTED
EQM Midstream Partners, LP
EQM
| $12.9M | 0.01% |
167,592
+9,316
| +6% | +$690K |
|
460
ProQR Therapeutics
PRQR
$248M
| $12.7M | 0.01% |
2,585,047
-31,920
| -1% | -$164K |
|
461
Under Armour
UAA
$3.04B
| $12.6M | 0.01% |
432,893
-28,464
| -6% | -$934K |
|
|
AEUA
462
DELISTED
Anadarko Petroleum Corporation
AEUA
| $12.4M | 0.01% |
299,496
+53,376
| +22% | +$2.24M |
|
463
CALL
Humana
HUM
$46.7B
| $12.2M | 0.01% |
60,000
-20,000
| -25% | -$3.81M |
|
464
Rocket Pharmaceuticals
RCKT
$343M
| $12.1M | 0.01% |
495,211
+1,173
| +0.2% | +$33.5K |
|
|
DM
465
DELISTED
Dominion Energy Midstream Ptr LP
DM
| $12M | 0.01% |
407,074
| – | – |
|
466
Natera
NTRA
$36.1B
| $11.7M | 0.01% |
999,823
+2,132
| +0.2% | +$23.5K |
|
|
CSOD
467
DELISTED
Cornerstone OnDemand, Inc.
CSOD
| $11.5M | 0.01% |
272,675
-1,193,335
| -81% | -$47.4M |
|
468
Liberty Global Class C
LBTYK
$3.4B
| $11.5M | 0.01% |
386,046
-4,605
| -1% | -$141K |
|
|
NS
469
DELISTED
NuStar Energy L.P.
NS
| $11.2M | 0.01% |
225,870
+16,986
| +8% | +$809K |
|
|
NSU
470
DELISTED
Nevsun Resources Ltd.
NSU
| $11.1M | 0.01% |
+3,592,387
| New | +$10.9M |
|
|
XOG
471
DELISTED
Extraction Oil & Gas, Inc. Common Stock
XOG
| $11M | 0.01% |
+548,243
| New | +$11.7M |
|
|
AM
472
DELISTED
ANTERO MIDSTREAM PARTNERS LP
AM
| $11M | 0.01% |
355,534
+148,929
| +72% | +$4.28M |
|
|
GPOR
473
DELISTED
Gulfport Energy Corp.
GPOR
| $10.8M | 0.01% |
498,209
-297,964
| -37% | -$7.65M |
|
474
Waste Management
WM
$96.1B
| $10.6M | 0.01% |
150,034
+103,664
| +224% | +$6.93M |
|
475
ExxonMobil
XOM
$634B
| $10.3M | 0.01% |
114,229
+64,573
| +130% | +$5.64M |
|
Similar funds
Jennison Associates's Q4 2016 Portfolio in Review
As of Q4 2016, Jennison Associates held 857 positions worth $89.6B, down 3.4% from $92.8B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Jennison Associates withdrew a net $3.76B in Q4 2016, closing 52 positions and reducing 313 holdings. Its most notable exit was lululemon athletica, an estimated $342M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Jennison Associates opened a new position in Parker-Hannifin worth $606M.
- Jennison Associates's largest Q4 2016 buy was Parker-Hannifin: 4,330,276 shares worth $606M.
- Jennison Associates added most to Charter Communications in Q4 2016, an estimated $601M increase.
- Jennison Associates's biggest Q4 2016 reduction was Biogen, cutting an estimated $733M.
- Jennison Associates fully exited lululemon athletica in Q4 2016, selling an estimated $342M.
- Jennison Associates's ten largest holdings make up 25% of its $89.6B portfolio in Q4 2016.
- Jennison Associates opened 208 new positions and closed 52 in Q4 2016.
- Jennison Associates's portfolio value fell 3.4% quarter-over-quarter to $89.6B.
Based on Jennison Associates's 13F filing for Q4 2016, filed 6 Feb 2017.